A detailed history of Calamos Advisors LLC transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Calamos Advisors LLC holds 207,429 shares of CDMO stock, worth $2.57 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
207,429
Holding current value
$2.57 Million
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$6.7 - $12.45 $1.39 Million - $2.58 Million
207,429 New
207,429 $2.36 Million
Q3 2021

Oct 26, 2021

SELL
$19.05 - $28.32 $4.52 Million - $6.72 Million
-237,459 Closed
0 $0
Q2 2021

Jul 22, 2021

BUY
$18.93 - $25.65 $1.55 Million - $2.1 Million
81,794 Added 52.54%
237,459 $6.09 Million
Q1 2021

Apr 12, 2021

BUY
$11.86 - $21.77 $1.85 Million - $3.39 Million
155,665 New
155,665 $2.84 Million

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $771M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Calamos Advisors LLC Portfolio

Follow Calamos Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.